Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-month open-label extension of pregabalin in pediatric patients with partial-onset seizures
2010-020731-39Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in Focal onset seizure, sponsored by Pfizer. Primary endpoint: Safety and tolerability. Started Sep 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal onset seizure
Beyond the preview
Go deeper on 2010-020731-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020731-39.